Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest NFCR Stories

2013-01-29 12:27:57

BETHESDA, Md., Jan. 29, 2013 /PRNewswire/ -- The National Foundation for Cancer Research (NFCR) announced today that Dr. Alex Matter has been awarded the 8(th) Szent-Gyorgyi Prize for Progress in Cancer Research for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer. This first targeted cancer therapy, imatinib mesylate, or Gleevec, contributed to a major breakthrough in the treatment of Chronic Myelogenous Leukemia (CML), followed by...

2011-09-16 17:31:00

BETHESDA, Md., Sept. 16, 2011 /PRNewswire/ -- National Foundation for Cancer Research (NFCR) co-founder Albert Szent-Gyorgyi, is being honored today, by Google on his 118th birthday, for his discovery of vitamin-C. The honor is a tribute to a life full of discoveries. Dr. Szent-Gyorgyi went on to co-found the NFCR along with entrepreneur Franklin C. Salisbury in 1973, so that scientists could find funding for high-risk, high reward research. "Dr. Szent-Gyorgyi was committed to the...

2011-03-08 07:05:00

BETHESDA, Md., March 8, 2011 /PRNewswire/ -- The National Foundation for Cancer Research (NFCR) announced today that Beatrice Mintz, Ph.D. has been awarded the 6th Annual Szent-Gyorgyi Prize for Progress in Cancer Research. Dr. Mintz, Professor and Jack Schultz Chair in Basic Science at the Fox Chase Cancer Center in Philadelphia, PA, received the Prize for her discoveries of the relationship between development and cancer, based on construction and analysis of chimeric and transgenic...

2011-02-28 13:47:00

NEW YORK, Feb. 28, 2011 /PRNewswire/ -- The Albert Szent-Gyorgyi Prize for Progress in Cancer Research, one of the most prestigious awards in the field of cancer research, will be awarded on Tuesday, March 8 at The Westin New York at Times Square. Media are invited and encouraged to attend. Named in memory of 1937 Nobel Laureate and NFCR Co-Founder Albert Szent-Gyorgyi, the Prize is awarded annually to a scientist, nominated by his or her peers, who has made outstanding contribution...

2010-12-23 00:00:54

A new property of a gene known for its involvement in tumor cell development, growth, and metastasis has been discovered by National Foundation for Cancer Research scientist Paul B. Fisher, M.Ph., Ph.D. and his team at Virginia Commonwealth University. The researchers discovered that the AEG-1 gene protects cancer cells from destruction by chemotherapy, thus enabling aggressive cancers to withstand treatment. This property of the AEG-1 gene was previously unknown. Bethesda, MD (PRWEB)...

2010-03-16 10:20:00

BETHESDA, Md., March 16 /PRNewswire/ -- The National Foundation for Cancer Research announced today that renowned scientist Peter K. Vogt, Ph.D., Professor in the Department of Molecular and Experimental Medicine at The Scripps Research Institute, La Jolla, California, is the recipient of the 5th Annual Szent-Gyorgyi Prize for Progress in Cancer Research. Dr. Vogt's research, which began on a humble chicken virus in the early 1960s, has profoundly changed biology and medicine. His...